[ad_1] Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy targeting LN and SLE ROCKVILLE, Md., Nov. 16, 2024 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta” or the “Company”), a global clinical-stage biopharmaceutical company focused on the discovery and […]
